Avoidance of hepatitis C transmission: a major advantage for PD in an Indian center.
Taduri
G
G
Murty
K V D
KV
Pillalamarri
N P
NP
Lakshmi
M
M
D018562:Disease Transmission, Infectious / Q000517:prevention & control*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005500:Follow-Up Studies; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology; D006526:Hepatitis C / Q000453:epidemiology* / Q000635:transmission / Q000821:virology; D018937:Hepatitis C Antibodies / Q000276:immunology; D006801:Humans; D007194:India / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory; D015995:Prevalence; D012367:RNA, Viral / Q000235:genetics; D012189:Retrospective Studies; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013997:Time Factors
D018937:Hepatitis C Antibodies; D012367:RNA, Viral